15 completed. 15 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 15 | Completed 15 |
Follow Microbial Collagenase: new trials by email Literature Review of Microbial Collagenase trials Research Report on Microbial Collagenase
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of Splinting After Collagenase Injection Collagenase Clostridium Histolyticum 0.9 MG [Xiaflex], Xiaflex + Hand-Based Custom Orthosis - Dupuytren Contracture, Dupuytren's Disease | Phase 3 | Completed | Foundation for Orthopaedic Research and Education | 80 | 2021-07-12 | 2025-02-26 |
| Evaluation of Xiaflex: Trial of Effectivenss iN Dupuytren's collagenase injection, limited palmar fasciectomy - Dupuytren's Disease | Phase 3 | Completed | McMaster University | 22 | 2017-07-08 | 2023-07-18 |
| An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease AA4500, ErecAid® Esteem® Manual Vacuum Therapy System, Investigator Modeling - Peyronie's Disease | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 30 | 2014-10-01 | 2017-11-08 |
| Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures XIAFLEX / XIAPEX - Dupuytren's Contracture | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 715 | 2012-09-01 | 2017-10-05 |
| A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease AA4500 - Peyronie's Disease | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 189 | 2012-09-01 | 2017-10-05 |
| Collagenase Option for Reduction of Dupuytren's Contracture in Japan Collagenase Clostridium Histolyticum - Dupuytren's Contracture | Phase 3 | Completed | Asahi Kasei Therapeutics Corporation | 104 | 2012-05-01 | 2017-03-21 |
| Administration of Two Injections for Multiple Dupuytren's Contractures AA4500 collagenase clostridium histolyticum - Dupuytren's Contracture | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 60 | 2011-09-01 | 2017-10-05 |
| A Study of AA4500 in Men With Peyronie's Disease AA4500 - Peyronie's Disease | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 348 | 2010-11-01 | 2017-10-05 |
| Study of AA4500 in the Treatment of Peyronie's Disease AA4500, Placebo - Peyronie's Disease | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 418 | 2010-10-01 | 2017-10-05 |
| Study of AA4500 in the Treatment of Peyronie's Disease AA4500, Placebo - Peyronie's Disease | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 418 | 2010-09-01 | 2017-10-05 |
| AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease AA4500 - Advanced Dupuytren's Disease | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 286 | 2007-12-01 | 2017-12-02 |
| Safety and Efficacy Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease collagenase clostridium histolyticum - Advanced Dupuytren's Disease | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 201 | 2007-10-01 | 2017-12-02 |
| Non-US Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease collagenase clostridium histolyticum - Advanced Dupuytren's Disease | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 66 | 2007-08-01 | 2017-12-02 |
| AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's Contracture collagenase clostridium histolyticum, Placebo - Dupuytren's Contracture | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 308 | 2007-08-01 | 2017-12-02 |
| Collagenase in the Treatment of Dupuytrens Disease collagenase clostridium histolyticum - Dupuytren's Disease | Phase 3 | Completed | Stony Brook University | 38 | 2003-06-01 | 2010-12-09 |
Dupuytren Contracture (7) · Penile Induration (5) · Contracture (1)
Endo USA Inc., a Keenova Therapeutics Company (11) · Asahi Kasei Therapeutics Corporation (1) · Foundation for Orthopaedic Research and Education (1) · McMaster University (1) · Stony Brook University (1)
United States (10) · Australia (4) · United Kingdom (2) · Canada (1) · Denmark (1) · France (1) · Germany (1) · Italy (1) · Japan (1) · New Zealand (1) · Spain (1) · Sweden (1)
Veronica Urdaneta, MD (4) · Gregory J. Kaufman, MD (2) · Gregory Kaufman, MD (2) · Veronica Urdaneta, MD, MPPH (2) · Achilleas Thoma, MD MSc FRCSC (1) · Jason Nydick, DO (1) · Lawrence C Hurst, MD (1) · Neil Shusterman, MD (1)
PMID 26199168, PMID 19726771, PMID 21967070, PMID 25388099, PMID 27313184, PMID 28974406